Biotechnology from bench to business

• Follow GEN on:
• Log In / Register | Subscribe

Current Issue

Top Keywords

• ADME/Tox
• Angiogenesis
• Apoptosis
• Antibodies
• Biomanufacturing
• Biomarkers
• Bioreactors
• Biosimilars
• Biotherapeutics
• Cancer
• Cancer Stem Cells
• Cell Culture
• Cell-Based Assays
• Chromatography
• Contract Manufacturing
• Gene Expression
• Genetics
• Genomics
• Glycan Analysis
• HPLC
• Immunoassay
• Liquid Handling
• mAb Production
• mAb Therapeutics
• Microarrays
• Multiplexing
• Next-Generation Sequencing
• Peptide Therapeutics
• PCR
• Pharmacokinetics
• Protein Characterization
• Protein Expression
• Protein Production
• Protein Therapeutics
• qPCR
• Reagents
• RNA-Seq
• Sequencing
• Single-Use Systems
• Small Molecules
• Stem Cells
• Transfection
• Vaccines

miRNA - Related Content

• GEN Articles
• Insight & Intelligence™
• GEN News Highlights
• GEN Podcasts
• Video Channel
• New Products
• Events

GEN articles

• Feature Articles: miRNA Closes In on Therapeutic Potential
  
• Feature Articles: miRNAs & Psychiatric Disorders
  
• Tech Tips: miRNA-RNAi Delivery and Applications
  An Exclusive Q&A with Our Expert Panel
• Feature Articles: Inroads in R&D Advance Utility of miRNA
  Gene Regulators Show Promise as Biomarkers and Potential Therapeutics
• Feature Articles: miRNA Drugs Close In on Clinical Debut
  Emerging Research Corroborates Potential for Broad Application Across Many Diseases

• MORE MIRNA RELATED GEN ARTICLES

Insight & intelligence™

• Chasing the Therapeutic Potential of miRNAs
  September 10, 2009
  The spate of deal-making, new company formations, and patent applications have set up miRNAs as the next wave in nucleic acid-based drugs.

• MORE MIRNA RELATED INSIGHT & INTELLIGENCE™

GEN news highlights

• Firefly Bags $500K from Massachusetts Life Science Center for miRNA Biomarker Platform
  
• Photoreactive Probe Technique Identifies mRNA Targets of miRNAs in Live Cells
  
• MiRagen Pockets $20M to Further miRNA-Based Drugs
  
• MicroRNA IDed as Target to Prevent aGVHD in Transplant Recipient Leukemia Patients
  
• miRagen and Silence Evaluate Liver-Targeting Delivery Platform for miRNAs
  

• MORE MIRNA RELATED GEN NEWS HIGHLIGHTS

GEN podcasts

• miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY
  - Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology
• SINGLE miRNA MOLECULE CONTROLS BLOOD VESSEL DEVELOPMENT
  - Interview with Jason Fish, Ph.D., Postdoctoral Fellow in the Laboratory of Deepak Srivastava at the Gladstone Institute of Cardiovascular Disease
• miRNAs AND CANCER
  - Interview with George Calin, M.D., Ph.D., Associate Professor, Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center

• MORE MIRNA RELATED GEN PODCASTS

Video channel

• Exiqon: ISH by LNA™
  

• MORE MIRNA RELATED VIDEO CHANNEL

New products

	Sigma-Aldrich Corporation Gene Target Identification The Mission Target ID Library enables benchtop transcriptome-wide human miRNA and ncRNA gene target identification. The Target ID Library is a transcriptome-wide cDNA pool; the library’s plasmids each have a human cDNA inserted into the 3&acut
	Phalanx Biotech Group microRNA Expression Profiling The OneArray® microRNA expression-profiling microarrays have been updated based on the latest miRBase release (version 17). This miRBase release features an increase over the previous version in the number of microRNA sequences, with 2,406 addit

• MORE MIRNA RELATED NEW PRODUCTS

Events

• miRNA: Tools and Technologies for the Quantitative and Functional Analysis in Mammalian Cells
  2012 May 29 - May 31 Bethesda, MD, UNITED STATES

• MORE MIRNA RELATED EVENTS

Home | Terms of Use | Privacy Statement | Legal